DS7300-188 icon

DS7300-188 vVARY

Download Options
View on Google Play

Screenshots

DS7300-188 screenshot 0 DS7300-188 screenshot 1

About this app

You are invited to participate in the Daiichi Sankyo - DS7300-188 study.

A Phase 3, Multicenter, Randomized, Open Label Study Of Ifinatamab Deruxtecan (I Dxd), A B7-H3 Antibody Drug Conjugate (Adc), Versus Treatment Of Physician’s Choice (Tpc) In Subjects With Relapsed Small Cell Lung Cancer (Sclc). This app is specifically intended for participants in the ds7300-188 study only.

Version Information

Version
-
Downloads
10+
Updated on
-
Released
Apr 22, 2024
Requires
Android Varies with device

Ratings & Reviews

0 ratings

More from Medable Inc.

See more apps

Explore Tags

Browse all tags